This provider's $15.5M in total Medicare payments ranks in the 94th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 106294% from 2017 to 2023.
96% of their billing comes from a single procedure code (K1034 — Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count).
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 8992% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2017 | $141.72 | $21.48 | 6.60x | $120.24 | $14.0K | 650 | 15 |
| 2018 | $46.66 | $14.08 | 3.31x | $32.58 | $957.69 | 68 | 4 |
| 2019 | $73.13 | $20.03 | 3.65x | $53.10 | $13.1K | 652 | 8 |
| 2020 | $201.49 | $62.70 | 3.21x | $138.79 | $454.9K | 7.3K | 6 |
| 2021 | $173.20 | $52.89 | 3.27x | $120.31 | $163.4K | 3.1K | 5 |
| 2023 | $25.00 | $11.76 | 2.13x | $13.24 | $14.9M | 1.3M | 1 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 1.3M | $14.9M | $11.76 | 2.13x |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.7K | $337.8K | $90.61 | 3.30x |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 3.3K | $139.7K | $42.13 | 3.32x |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.4K | $72.7K | $51.31 | 2.92x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 1.4K | $34.9K | $25.00 | 3.00x |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 60 | $14.8K | $246.92 | 3.00x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 104 | $10.4K | $100.00 | 3.00x |
| 80307 | Testing for presence of drug, by chemistry analyzers | 60 | $3.7K | $62.14 | 3.00x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 125 | $2.9K | $23.46 | 3.25x |
| 82670 | Estradiol (hormone) level | 72 | $2.4K | $33.98 | 5.49x |
| 84403 | Testosterone (hormone) level | 74 | $2.3K | $31.40 | 5.33x |
| 84402 | Testosterone (hormone) level | 74 | $2.3K | $30.98 | 5.33x |
| 80053 | Blood test, comprehensive group of blood chemicals | 167 | $1.9K | $11.24 | 4.28x |
| 84144 | Progesterone (reproductive hormone) level | 69 | $1.7K | $25.27 | 5.15x |
| 83001 | Gonadotropin, follicle stimulating (reproductive hormone) level | 71 | $1.6K | $22.58 | 5.31x |
| 83002 | Gonadotropin, luteinizing (reproductive hormone) level | 70 | $1.6K | $22.46 | 5.23x |
| 82627 | Dehydroepiandrosterone (DHEA-S) hormone level | 56 | $1.5K | $26.25 | 5.07x |
| 84481 | Thyroid hormone, T3 measurement | 73 | $1.4K | $19.77 | 5.21x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 154 | $1.4K | $8.82 | 4.28x |
| 84443 | Blood test, thyroid stimulating hormone (TSH) | 66 | $1.3K | $20.06 | 4.42x |
This provider submits charges 2.18 times higher than what Medicare actually pays.
A markup ratio of 2.18x means for every $100 Medicare pays, this provider initially charges $218. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in TX for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Clinical Pathology Laboratories, Inc. | Austin, TX | $541.0M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Irving, TX | $453.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Dallas, TX | $389.6M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Houston, TX | $311.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Houston, TX | $299.4M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data